Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17634350 | 1.00 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL1005543 | 1.00 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL17634351 | 1.00 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL17627631 | 1.00 | ALOX15 (0.46) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL19538266 | 0.72 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL3504932 | 0.72 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL24722701 | 0.72 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL8739039 | 0.72 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL1937904 | 0.72 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 | |
| SCHEMBL22053015 | 0.72 | ALOX15 (0.41) | ALOX15ALDH1A1LMNATHRBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4013438-A1 | HERBAL PREPARATION FOR STIMULATION OF HAIR GROWTH, CONTROL OF HAIR FALL, DANDRUFF AND INFECTIONS THEREOF USING AGERATUM SPP | GE Nutrients, Inc. (US) | 2022-06-22 | — | — | EP | claimed |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | disclosed |
| US-12458653-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-11-04 | — | — | US | disclosed |
| US-20250332140-A1 | OPHTHALMIC FORMULATIONS AND METHODS OF USE | VISION SOLUTIONS LLC (US) | 2025-10-30 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| US-20250255915-A1 | OPHTHALMIC FORMULATIONS AND METHODS OF USE | VISION SOLUTIONS LLC (US) | 2025-08-14 | — | — | US | disclosed |
| US-12311004-B2 | Ophthalmic formulations and methods of use | VISION SOLUTIONS, LLC (US) | 2025-05-27 | — | — | US | disclosed |
| US-12303488-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2025-05-20 | — | — | US | disclosed |
| US-20250099524-A1 | OPHTHALMIC FORMULATIONS AND METHODS OF USE | VISION SOLUTIONS, LLC | 2025-03-27 | — | — | US | disclosed |
| US-20230405067-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2023-12-21 | — | — | US | disclosed |
| US-20230346739-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC | 2023-11-02 | — | — | US | disclosed |
| US-20230293480-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC | 2023-09-21 | — | — | US | disclosed |
| US-20230293555-A1 | COMPOSITIONS COMPRISING CANNABIDIOL AND FLAVANONES | YUZU LV LLC | 2023-09-21 | — | — | US | disclosed |
| US-11684604-B2 | Cannabis based therapeutic and method of use | YUZU LV LLC (US) | 2023-06-27 | — | — | US | disclosed |
| US-20220387537-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2022-12-08 | — | — | US | disclosed |
| EP-4013438-A1 | HERBAL PREPARATION FOR STIMULATION OF HAIR GROWTH, CONTROL OF HAIR FALL, DANDRUFF AND INFECTIONS THEREOF USING AGERATUM SPP | GE Nutrients, Inc. (US) | 2022-06-22 | — | — | EP | disclosed |
| US-11357809-B2 | Herbal preparation for stimulation of hair growth, control of hair fall, dandruff and infections thereof using Ageratum spp | GE NUTRIENTS, INC. (US) | 2022-06-14 | — | — | US | disclosed |
| US-20220159950-A1 | INSECT REPELLING COMPOSITION | GLOBAL BIOLIFE INC. | 2022-05-26 | — | — | US | disclosed |
| US-11246310-B2 | Insect repelling composition | GLOBAL BIOLIFE INC. (US) | 2022-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332140-A1 | OPHTHALMIC FORMULATIONS AND METHODS OF USE | FAHD1, TIE1, OXSR1 | ALOX15 2594/4885ALDH1A1 766/4885LMNA 2574/4885 |
| US-11684604-B2 | Cannabis based therapeutic and method of use | CNR2, CNR1, OPRK1 | ALOX15 369/4885ALDH1A1 3206/4885LMNA 4763/4885 |
| US-12311004-B2 | Ophthalmic formulations and methods of use | FAHD1, TIE1, OXSR1 | ALOX15 2594/4885ALDH1A1 766/4885LMNA 2574/4885 |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | ALOX15 11/4885ALDH1A1 1420/4885LMNA 293/4885 |
| US-11357809-B2 | Herbal preparation for stimulation of hair growth, control of hair fall, dandruff and infections thereof using Ageratum spp | HES1, AGER, IL36G | ALOX15 1130/4885ALDH1A1 1080/4885LMNA 4644/4885 |
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | ALOX15 121/4885ALDH1A1 4768/4885LMNA 3179/4885 |
| US-20250255915-A1 | OPHTHALMIC FORMULATIONS AND METHODS OF USE | FAHD1, TIE1, OXSR1 | ALOX15 2594/4885ALDH1A1 766/4885LMNA 2574/4885 |
| US-20250099524-A1 | OPHTHALMIC FORMULATIONS AND METHODS OF USE | FAHD1, TIE1, OXSR1 | ALOX15 2594/4885ALDH1A1 766/4885LMNA 2574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.